JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Scope & Guideline

Leading the way in infectious disease innovation.

Introduction

Welcome to the JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1525-4135
PublisherLIPPINCOTT WILLIAMS & WILKINS
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1988 to 1994, from 1996 to 1997, from 1999 to 2024
AbbreviationJAIDS-J ACQ IMM DEF / JAIDS
Frequency15 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103

Aims and Scopes

JAIDS - Journal of Acquired Immune Deficiency Syndromes focuses on the comprehensive study of HIV/AIDS, emphasizing both clinical and epidemiological aspects. The journal seeks to disseminate research that advances the understanding of HIV/AIDS prevention, treatment, and management, with a commitment to addressing health disparities and improving outcomes for affected populations.
  1. Clinical Research:
    Investigates treatment regimens, drug efficacy, and patient outcomes related to antiretroviral therapy and other interventions for individuals living with HIV.
  2. Epidemiological Studies:
    Focuses on the patterns, causes, and effects of HIV infection in various populations, utilizing data to inform public health strategies.
  3. Behavioral and Social Sciences:
    Explores the impact of social determinants, stigma, and mental health on HIV prevention and treatment adherence.
  4. Innovative Prevention Strategies:
    Examines new approaches to HIV prevention, including pre-exposure prophylaxis (PrEP), vaccination studies, and community-based interventions.
  5. Intersection with Other Health Issues:
    Investigates the co-morbidities associated with HIV, including mental health, substance use, and chronic diseases that affect treatment and quality of life.
  6. Health Policy and Implementation Research:
    Studies the implementation of HIV care models and policies, aiming to improve access and quality of care for diverse populations.
JAIDS is at the forefront of emerging research trends in the field of HIV/AIDS, with a clear pivot towards addressing contemporary challenges faced by populations affected by HIV. The following themes have gained traction in recent publications, reflecting the evolving landscape of HIV research.
  1. Integration of Mental Health and HIV Care:
    There is an increasing focus on the intersection of mental health and HIV treatment, recognizing the importance of addressing psychological factors in improving health outcomes.
  2. Impact of COVID-19 on HIV Care:
    Research exploring how the COVID-19 pandemic has affected HIV testing, treatment adherence, and health outcomes is rapidly emerging, highlighting the need for resilient health systems.
  3. Use of Technology in HIV Prevention and Treatment:
    The incorporation of digital health solutions, telemedicine, and mobile health interventions to enhance HIV care and prevention efforts is a growing area of interest.
  4. Social Justice and Health Disparities:
    A rising trend in addressing social determinants of health, particularly the disparities experienced by marginalized communities in accessing HIV care and prevention.
  5. Long-Acting Antiretroviral Therapies:
    Research on long-acting injectable treatments and their implementation in various settings is becoming increasingly prominent, reflecting a shift towards more convenient treatment options.

Declining or Waning

While JAIDS has consistently published impactful research, certain themes appear to be waning or declining in prominence. This may reflect shifts in research focus, funding opportunities, or changes in public health priorities.
  1. Basic Science Research:
    There has been a noticeable decline in purely laboratory-based studies focusing on the molecular biology of HIV, as the journal shifts towards more applied clinical and public health research.
  2. HIV Vaccine Development:
    Research specifically dedicated to vaccine trials and related immunology studies has decreased, possibly due to the focus on therapeutic interventions and prevention strategies like PrEP.
  3. HIV Transmission Dynamics Modeling:
    Although still relevant, there appears to be less emphasis on theoretical modeling studies regarding HIV transmission dynamics, as the focus has shifted towards practical implementation of interventions.

Similar Journals

Asia-Pacific Journal of Public Health

Elevating public health discourse in the Asia-Pacific.
Publisher: SAGE PUBLICATIONS INCISSN: 1010-5395Frequency: 8 issues/year

Asia-Pacific Journal of Public Health, published by SAGE Publications Inc, is a leading platform for disseminating scholarly research in the field of public health. With an impressive scope that spans from the late 1980s to the present, the journal offers a wealth of articles that address critical issues faced by diverse populations in the Asia-Pacific region. Categorized in the Q3 quartile for both Medicine (miscellaneous) and Public Health, Environmental and Occupational Health, it holds a significant position within its field, ranked 310 out of 665 in the Scopus database. Researchers and professionals have access to valuable insights that inform public health policy and practice, making this journal an essential resource for those aiming to enhance health outcomes in the region. While not currently open access, the journal's rigorous peer-review process ensures the integrity and relevance of its content. As the landscape of public health continues to evolve, the Asia-Pacific Journal of Public Health remains a vital resource for advancing knowledge, fostering collaboration, and promoting a healthier society.

Preventive Medicine

Elevating epidemiology for a healthier future.
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0091-7435Frequency: 12 issues/year

Preventive Medicine is a premier academic journal published by Academic Press Inc Elsevier Science, renowned for its influential contributions to the fields of Epidemiology and Public Health. Since its inception in 1946 and through its dedicated issues leading into 2024, the journal has established itself as a leading platform for cutting-edge research, boasting impressive Scopus rankings, with a notable Q1 status across relevant categories. This journal provides an essential forum for scholars, practitioners, and policy-makers interested in the prevention of diseases and the promotion of health within populations. With each issue, it disseminates valuable insights on preventive strategies, health behaviors, and epidemiological trends, making it crucial for anyone invested in the advancement of public health sciences. The journal does not offer open access options, ensuring that content remains relevant and targeted to its scholarly audience. Given its valuable contributions and recognition in the academic community, Preventive Medicine continues to play a pivotal role in shaping evidence-based approaches to health promotion and disease prevention in modern societal contexts.

Lancet HIV

Championing evidence-based approaches to HIV management.
Publisher: ELSEVIER INCISSN: 2352-3018Frequency: 12 issues/year

The Lancet HIV, published by Elsevier Inc in the United Kingdom, stands at the forefront of HIV research and public health, providing a vital platform for the dissemination of innovative findings and critical knowledge in the fields of epidemiology, immunology, infectious diseases, and virology. With its prestigious Q1 rankings in the aforementioned categories for 2023, the journal is recognized for its significant contribution to advancing understanding and addressing challenges posed by HIV globally. Its impressive standing, including a Scopus ranking in the 94th percentile for multiple categories, underscores its impact within the research community. The Lancet HIV publishes rigorously peer-reviewed research articles, reviews, and opinion pieces, ensuring that all stakeholders—researchers, practitioners, and policymakers—are engaged with up-to-date, evidence-based perspectives. Researchers and students alike will find this journal an invaluable resource for enhancing their knowledge and contributing to the ongoing discourse surrounding HIV treatment and prevention.

HIV MEDICINE

Exploring Breakthroughs in HIV Medicine and Policy
Publisher: WILEYISSN: 1464-2662Frequency: 10 issues/year

HIV Medicine is a prestigious journal published by Wiley that stands at the forefront of research in the fields of health policy, infectious diseases, and pharmacology, with a commendable impact factor reflected in its Q1 rankings for 2023. Established in 1999 and set to converge its expertise through 2024, this journal plays a critical role in advancing the understanding and treatment of HIV and related health challenges. It is esteemed for its rigorous peer-review process and its contributions to both clinical and policy-oriented discussions surrounding HIV medicine. With a broad international readership, it serves as a vital resource for researchers, healthcare professionals, and students committed to fighting the global HIV epidemic. Although not open access, its vital insights are indispensable for anyone involved in infectious disease research and healthcare policy. Articles published in HIV Medicine shape global health strategies and influence the future of HIV research, making it a must-read for those dedicated to this crucial field.

AIDS Research and Treatment

Shaping the future of HIV/AIDS research.
Publisher: HINDAWI LTDISSN: 2090-1240Frequency: 1 issue/year

AIDS Research and Treatment is a premier open access journal published by HINDAWI LTD, dedicated to advancing the understanding and treatment of HIV/AIDS and related conditions. Launched in 2010, the journal has established itself as a vital resource for researchers, healthcare professionals, and students in the fields of Dermatology, Immunology, Infectious Diseases, and Public Health. With a notable 2023 impact factor reflected in its Q2 and Q3 quartile rankings across key medical categories, the journal plays a critical role in disseminating high-quality research and fostering innovation in the prevention and treatment of AIDS. It provides a wide range of open access options, enabling easier dissemination and increased visibility of research findings globally. As the landscape of HIV/AIDS research continues to evolve, AIDS Research and Treatment remains at the forefront, ensuring crucial insights and developments are shared to enhance public health outcomes.

INTERNATIONAL JOURNAL OF STD & AIDS

Elevating the discourse on public health and infectious diseases.
Publisher: SAGE PUBLICATIONS LTDISSN: 0956-4624Frequency: 12 issues/year

INTERNATIONAL JOURNAL OF STD & AIDS is a prominent publication dedicated to advancing the understanding and treatment of sexually transmitted diseases and HIV/AIDS. Published by SAGE Publications Ltd, this esteemed journal has been contributing to the medical community since 1990, with a convergence of studies spanning to 2024. With its ISSN 0956-4624 and E-ISSN 1758-1052, the journal is recognized for its rigorous peer-reviewed research and has successfully positioned itself in the second quartile (Q2) of Dermatology and Public Health, alongside notable rankings in Infectious Diseases and Pharmacology. Currently based in the United Kingdom, this journal serves as a crucial resource for researchers, healthcare professionals, and students, providing a platform for innovative studies and critical reviews that address global health challenges. Although it does not offer Open Access, the journal continues to maintain its reputation as a vital reference point for those invested in the fields of dermatology, public health, and infectious diseases.

ADDICTION

Advancing knowledge in addiction science.
Publisher: WILEYISSN: 0965-2140Frequency: 12 issues/year

ADDICTION, published by Wiley, is a highly regarded academic journal that serves the vibrant fields of Medicine and Psychiatry and Mental Health. With an impressive impact factor reflective of its significance—ranking in the top 8% and 7.5% of its categories respectively—this journal is esteemed for its rigorous peer-reviewed research which spans a wide array of topics related to addiction, including pharmacology, prevention, and treatment modalities. Since its inception in 1993, ADDICTION has continually provided a platform for innovative research, shaping the discourse and influencing clinical practices worldwide. This journal, based in the United Kingdom at a prestigious location in Hoboken, NJ, stands as a beacon for researchers, practitioners, and students alike, committed to advancing understanding and strategies to combat addiction-related challenges. Although it is not an Open Access publication, the journal's contribution to the field remains invaluable, ensuring that cutting-edge findings are disseminated widely among professionals dedicated to improving mental health outcomes.

Journal of the International Association of Providers of AIDS Care

Advancing Knowledge in HIV/AIDS Care and Research
Publisher: SAGE PUBLICATIONS INCISSN: 2325-9574Frequency: 1 issue/year

Journal of the International Association of Providers of AIDS Care, published by SAGE PUBLICATIONS INC, is a distinguished open-access journal dedicated to the field of HIV/AIDS care and research. Since its inception in 2002, the journal has provided an essential platform for the dissemination of high-quality, peer-reviewed scholarly articles that advance knowledge in exciting areas such as dermatology, immunology, and infectious diseases. With an impact factor that highlights its role in shaping ongoing discourse, the journal boasts a strong reputation, reflected in its Q1 status in Dermatology and consistent ranking in the top tiers for immunology and infectious diseases in the Scopus Ranks. This commitment to excellence ensures that researchers, healthcare professionals, and students have access to the latest advancements and best practices in HIV/AIDS prevention and care. As a pivotal resource in the global health landscape, the journal stands at the forefront of efforts to combat the challenges presented by this ongoing epidemic.

Annals of Clinical Psychiatry

Pioneering Innovations in Clinical Mental Health.
Publisher: QUADRANT HEALTHCOM INCISSN: 1040-1237Frequency: 4 issues/year

Annals of Clinical Psychiatry, published by QUADRANT HEALTHCOM INC, is a leading journal in the fields of Medicine and Psychiatry & Mental Health. With its longstanding commitment to advancing clinical knowledge since 1989, this esteemed journal contributes invaluable insights into current psychiatric practices and mental health research. The journal is recognized in the Scopus ranking with a position in the 34th percentile, reflective of its focused scope and substantial academic contributions. While access to the journal is tailored for professionals and researchers, the absence of Open Access highlights the journal's dedication to maintaining quality and rigorous peer-reviewed standards. As part of the Q3 quartile for both Medicine and Psychiatry categories in 2023, Annals of Clinical Psychiatry serves as an essential resource for those dedicated to improving mental health outcomes, making it a vital platform for practitioners, researchers, and students alike. Situated in Parsippany, New Jersey, the journal remains a pivotal entity that fosters scholarly dialogue and exploration in clinical psychiatry.

Health Promotion and Chronic Disease Prevention in Canada-Research Policy and Practice

Driving discussions to shape the future of health promotion.
Publisher: PUBLIC HEALTH AGENCY CANADAISSN: 2368-738XFrequency: 4 issues/year

Health Promotion and Chronic Disease Prevention in Canada - Research Policy and Practice is a leading open-access journal published by the Public Health Agency Canada. This journal, indexed with the ISSN 2368-738X, is dedicated to advancing the field of health promotion while addressing chronic disease prevention in the Canadian context. Since its inception in 2008, it has gained a robust reputation, evidenced by its ranking in the second quartile (Q2) across multiple categories including Epidemiology, Health Policy, and Public Health, Environmental and Occupational Health. With its emphasis on research and policy implications, the journal serves as a critical resource for researchers, healthcare professionals, and students alike, aiming to promote evidence-based practices and driving discussions that shape public health policies. The journal is particularly noted for its triangulation of research findings into actionable strategies, making it relevant for both academic inquiry and practical application. Whether you are seeking to enhance your knowledge or contribute to the discourse on chronic disease prevention, this journal offers a platform for sharing impactful research and innovative ideas.